(R)-N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide

ID: ALA4090631

Cas Number: 34811-66-0

PubChem CID: 6918904

Max Phase: Preclinical

Molecular Formula: C15H22N2O

Molecular Weight: 246.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(C)c1NC(=O)[C@H]1CCCCN1C

Standard InChI:  InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)/t13-/m1/s1

Standard InChI Key:  INWLQCZOYSRPNW-CYBMUJFWSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   27.3862  -12.2317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3862  -11.4084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6747  -10.9967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6747  -10.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3927   -9.7558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1041  -10.1734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1041  -10.9966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9634   -9.7498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9525  -11.4053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9525  -12.2286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6655  -12.6433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.2358  -12.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5191  -12.2207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8065  -12.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8065  -13.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5191  -13.8754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2358  -13.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5191  -11.3975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  4  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  2  0
 12 10  1  1
 12 13  1  0
 14 13  1  0
 15 14  1  0
 16 15  1  0
 17 16  1  0
 12 17  1  0
 13 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4090631

    (R)-Mepivacaine

Associated Targets(Human)

ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 246.35Molecular Weight (Monoisotopic): 246.1732AlogP: 2.73#Rotatable Bonds: 2
Polar Surface Area: 32.34Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.62CX Basic pKa: 7.25CX LogP: 3.19CX LogD: 2.96
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -1.02

References

1. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T..  (2012)  Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.,  40  (12): [PMID:22961681] [10.1124/dmd.112.047068]
2. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]
3. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]
4. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]